DE602006004963D1 - Kombination von methylxanthinverbindungen und steroiden zur behandlung chronischer atemwegserkrankungen - Google Patents

Kombination von methylxanthinverbindungen und steroiden zur behandlung chronischer atemwegserkrankungen

Info

Publication number
DE602006004963D1
DE602006004963D1 DE602006004963T DE602006004963T DE602006004963D1 DE 602006004963 D1 DE602006004963 D1 DE 602006004963D1 DE 602006004963 T DE602006004963 T DE 602006004963T DE 602006004963 T DE602006004963 T DE 602006004963T DE 602006004963 D1 DE602006004963 D1 DE 602006004963D1
Authority
DE
Germany
Prior art keywords
combination
treatment
steroids
respiratory diseases
chronic respiratory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006004963T
Other languages
English (en)
Inventor
Justian Craig Fox
Mary Frances Fitzgerald
Harry Finch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Argenta Discovery Ltd
Original Assignee
Argenta Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0502949A external-priority patent/GB0502949D0/en
Priority claimed from GB0526124A external-priority patent/GB0526124D0/en
Application filed by Argenta Discovery Ltd filed Critical Argenta Discovery Ltd
Publication of DE602006004963D1 publication Critical patent/DE602006004963D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
DE602006004963T 2005-02-11 2006-02-13 Kombination von methylxanthinverbindungen und steroiden zur behandlung chronischer atemwegserkrankungen Active DE602006004963D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0502949A GB0502949D0 (en) 2005-02-11 2005-02-11 Combination therapy
GB0526124A GB0526124D0 (en) 2005-12-22 2005-12-22 Inhaled combination therapy
PCT/GB2006/000482 WO2006085102A1 (en) 2005-02-11 2006-02-13 Combination of methylxanthine compounds and steroids to treat chronic respiratory diseases

Publications (1)

Publication Number Publication Date
DE602006004963D1 true DE602006004963D1 (de) 2009-03-12

Family

ID=36123283

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006004963T Active DE602006004963D1 (de) 2005-02-11 2006-02-13 Kombination von methylxanthinverbindungen und steroiden zur behandlung chronischer atemwegserkrankungen

Country Status (21)

Country Link
US (2) US8431553B2 (de)
EP (1) EP1845994B1 (de)
JP (1) JP5579368B2 (de)
CN (1) CN102526074B (de)
AT (1) ATE421325T1 (de)
AU (1) AU2006212022B2 (de)
BR (1) BRPI0606736A2 (de)
CA (1) CA2597384C (de)
CY (1) CY1108978T1 (de)
DE (1) DE602006004963D1 (de)
DK (1) DK1845994T3 (de)
ES (1) ES2321554T3 (de)
IL (1) IL183696A (de)
MX (1) MX2007009698A (de)
NO (1) NO338765B1 (de)
NZ (1) NZ555780A (de)
PL (1) PL1845994T3 (de)
PT (1) PT1845994E (de)
RU (1) RU2395285C2 (de)
SI (1) SI1845994T1 (de)
WO (1) WO2006085102A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8506934B2 (en) 2005-04-29 2013-08-13 Robert I. Henkin Methods for detection of biological substances
WO2008095136A2 (en) 2007-01-31 2008-08-07 Henkin Robert I Methods for detection of biological substances
NZ560460A (en) * 2007-08-07 2008-11-28 Ib Rosendal Andersen Stock prodder
US8580801B2 (en) 2008-07-23 2013-11-12 Robert I. Henkin Phosphodiesterase inhibitor treatment
CN102186458A (zh) * 2008-10-14 2011-09-14 艾克蒂维罗有限责任公司 治疗慢性阻塞性肺病及其它肺疾病的方法
US8712794B2 (en) * 2008-12-30 2014-04-29 The Invention Science Fund I, Llc Methods and systems for presenting an inhalation experience
US20100163034A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US20100163029A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method for administering an inhalable compound
US8738395B2 (en) 2008-12-30 2014-05-27 The Invention Science Fund I, Llc Methods and systems for presenting an inhalation experience
US8706518B2 (en) * 2008-12-30 2014-04-22 The Invention Science Fund I, Llc Methods and systems for presenting an inhalation experience
US8694330B2 (en) * 2008-12-30 2014-04-08 The Invention Science Fund I, Llc Methods and systems for presenting an inhalation experience
US20100168602A1 (en) * 2008-12-30 2010-07-01 Searete Llc Methods and systems for presenting an inhalation experience
US20100163027A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US20100169259A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US20100163025A1 (en) * 2008-12-30 2010-07-01 Searete Llc Methods and systems for presenting an inhalation experience
US20100168525A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US8725529B2 (en) * 2008-12-30 2014-05-13 The Invention Science Fund I, Llc Methods and systems for presenting an inhalation experience
US20100169260A1 (en) * 2008-12-30 2010-07-01 Searete Llc Methods and systems for presenting an inhalation experience
US20100166613A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
US20100163036A1 (en) * 2008-12-30 2010-07-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for presenting an inhalation experience
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
EP2813227A1 (de) * 2009-10-22 2014-12-17 Vertex Pharmaceuticals Incorporated Zusammensetzungen für die Behandlung von Mukoviszidose und anderen chronischen Erkrankungen
US8623924B2 (en) 2011-07-15 2014-01-07 Nusirt Sciences, Inc. Compositions and methods for modulating metabolic pathways
US20150297601A1 (en) * 2012-10-05 2015-10-22 Robert I. Henkin Phosphodiesterase inhibitor treatment
AU2013344753B2 (en) 2012-11-13 2018-09-27 Nusirt Sciences, Inc. Compositions and methods for increasing energy metabolism
US20150359771A1 (en) 2013-01-15 2015-12-17 Nusirt Sciences, Inc. Treating pulmonary conditions
CA2902879C (en) 2013-03-15 2023-09-26 Nusirt Sciences, Inc. Leucine and nicotinic acid reduces lipid levels
EP3108245B1 (de) 2014-02-18 2020-07-22 Robert I. Henkin Verfahren und zusammensetzungen zur diagnose und behandlung des verlustes und/oder der verzerrten wahrnehmung von geschmack oder geruch
SG11201607075TA (en) 2014-02-27 2016-09-29 Nusirt Sciences Inc Compositions and methods for the reduction or prevention of hepatic steatosis
UA111983C2 (uk) * 2014-04-29 2016-07-11 Микола Іванович Гуменюк Фармацевтична композиція для лікування хронічних обструктивних захворювань легень

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3622M (fr) 1964-05-04 1965-10-18 Inst Rech Scient Irs Association antiallergique.
GB8918297D0 (en) 1989-08-10 1989-09-20 Beecham Group Plc Novel treatment
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
GB9202519D0 (en) 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
GB2284761A (en) * 1993-12-03 1995-06-21 Euro Celtique Sa Prophylactic treatment of asthma
RU2212230C2 (ru) 1998-03-05 2003-09-20 Ниппон Синяку Ко., Лтд. Жировая эмульсия для ингаляции
GB0005199D0 (en) * 2000-03-04 2000-04-26 Imp College Innovations Ltd Modulation of histone deacetylase
SE0200312D0 (sv) * 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
US7550133B2 (en) * 2002-11-26 2009-06-23 Alexza Pharmaceuticals, Inc. Respiratory drug condensation aerosols and methods of making and using them
US20050026890A1 (en) 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
US20050026883A1 (en) 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026879A1 (en) 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or VCAM inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026848A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
US20050038004A1 (en) 2003-07-31 2005-02-17 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050026882A1 (en) 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20050043282A1 (en) 2003-07-31 2005-02-24 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a lipoxygenase inhibitor for treatment of asthma or chronic obstructive pulmonary disease
GB0417481D0 (en) 2004-08-05 2004-09-08 Etiologics Ltd Combination therapy

Also Published As

Publication number Publication date
NO20072920L (no) 2007-11-08
ATE421325T1 (de) 2009-02-15
IL183696A (en) 2014-03-31
NZ555780A (en) 2010-11-26
ES2321554T3 (es) 2009-06-08
US20080318913A1 (en) 2008-12-25
IL183696A0 (en) 2007-10-31
EP1845994A1 (de) 2007-10-24
RU2395285C2 (ru) 2010-07-27
NO338765B1 (no) 2016-10-17
CY1108978T1 (el) 2013-09-04
DK1845994T3 (da) 2009-05-04
US20100324002A1 (en) 2010-12-23
PL1845994T3 (pl) 2009-07-31
JP5579368B2 (ja) 2014-08-27
CA2597384C (en) 2014-01-21
SI1845994T1 (sl) 2009-06-30
US8426393B2 (en) 2013-04-23
JP2008530071A (ja) 2008-08-07
BRPI0606736A2 (pt) 2009-07-21
AU2006212022A1 (en) 2006-08-17
PT1845994E (pt) 2009-04-13
WO2006085102A1 (en) 2006-08-17
CA2597384A1 (en) 2006-08-17
CN102526074B (zh) 2016-05-18
RU2007130700A (ru) 2009-02-20
MX2007009698A (es) 2007-09-26
CN102526074A (zh) 2012-07-04
EP1845994B1 (de) 2009-01-21
US8431553B2 (en) 2013-04-30
AU2006212022B2 (en) 2011-02-03

Similar Documents

Publication Publication Date Title
ATE421325T1 (de) Kombination von methylxanthinverbindungen und steroiden zur behandlung chronischer atemwegserkrankungen
DE602005026007D1 (de) Opioide zur behandlung von chronisch-obstruktiver lungenerkrankung (copd)
ECSP055855A (es) Medicamentos en polvo para inhalación que contiene una sal de tiotropio y salmeterolxinafoato
EA200800007A1 (ru) Фармацевтические композиции на основе нейроактивного стероида и их применение
CY1117571T1 (el) Συνδυασμος αντιχολινεργικων και ανταγωνιστων υποδοχεα λευκοτριενιου για την αγωγη αναπνευστικων νοσηματων
ECSP024268A (es) Nuevos polvos para inhalacion que contienen tiotropio
DE602005017636D1 (de) Neue hydantoinderivate zur behandlung von obstruktiven atemwegserkrankungen
MX2019006938A (es) Metodos y composiciones para trataminto de hipertension pulmonar y otros trastornos del pulmon.
UA92584C2 (ru) Применение мелоксикама для лечения респираторных заболеваний у свиней
ECSP066544A (es) Nuevas sales de tiotropio, procedimientos para su preparación, así como formulaciones medicamentosas que las contienen
ECSP088902A (es) Derivados de pirazolo[3,4-d]-pirimidina utiles para tratar trastornos respiratorios
BRPI0514043A (pt) medicamentos para tratar doença respiratória crÈnica
UA98136C2 (ru) Применение аклидиния для лечения респираторных заболеваний
TW200720236A (en) Organic compounds
TW200604196A (en) New quinuclidine derivatives and pharmaceutical compositions comprising them
NO20054767L (no) Sammensetninger omfattende apomorfin for inhalering i lunge
NO20054180D0 (no) Behandling av bakterielle sykdommer i andedrettsorganene ved lokal tilforsel av fluorkinoloner
ATE482709T1 (de) Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen
TNSN07263A1 (en) Substituted 4-phenyl tetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them
UY28596A1 (es) Nuevo anhidrato cristalino con accion anticolinergica
EA201891931A1 (ru) Новые ингибиторы фосфатидилинозитол-3-киназы гамма
ECSP088287A (es) Una combinación de compuestos que puede ser utilizada en el tratamiento de enfermedades respiratorias, especialmente enfermedad pulmonar obstructiva crónica (epoc) y asma
ATE517877T1 (de) Neue arzneimittel zur behandlung von atemwegserkrankungen
MXPA04012728A (es) Deshidroepiandrosterona dihidratada y metodos para el tratamiento de asma o una enfermedad pulmonar obstructiva cronica utilizando composiciones de la misma.
NO20073909L (no) Forstover-formulering

Legal Events

Date Code Title Description
8364 No opposition during term of opposition